Compare Box Inc (BOX) vs Heron Therapeutics Inc (HRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Box Inc vs Heron Therapeutics Inc — how do they compare? Box Inc trades at $32.5 (market cap $4.55B), while Heron Therapeutics Inc trades at $0.36 (market cap $61.47M). The key difference: Box Inc is far larger — about 74× Heron Therapeutics Inc's market cap, and Box Inc is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| BOX | HRTX | |
|---|---|---|
Market Cap | $4.55B | $61.47M |
Sector | Technology | Health |
52-Week High | $33.60 | $1.49 |
52-Week Low | $21.37 | $0.32 |
Enterprise Value | $5.10B | $168.21M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BOX trades at $32.53, down 3.18% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $37.00. Revenue grew to $1.09 billion in 2025 with a net income margin of 22.43%, though the P/E ratio of 51.3 indicates a premium valuation. Recent news highlights Box's partnership with Quintas Energy for an AI-ready content platform, reinforcing its enterprise focus.
The outlook is positive with strong analyst support (60.72% buy ratings) and projected revenue growth to $1.2 billion in 2026. Risks include high valuation multiples and competitive pressures in cloud content management. Upside potential exists if earnings beat expectations, but investors should monitor debt levels and margin sustainability.
HRTX trades at $0.3152, down 4.54% today, amid bearish technical signals and mixed earnings. The stock shows a high gross margin of 70.07% but negative net income margins, with Q2 2026 missing revenue and EPS estimates. Recent news highlights patent litigation developments and quarterly results falling short of expectations, contributing to investor caution.
The outlook remains challenged by persistent losses and operational cash burn, though analyst consensus is strongly bullish with 94.74% buy ratings. Key risks include execution on product sales, competitive pressures, and reliance on financing activities to sustain operations amid negative profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Box Inc
Box is a cloud-based content services platform that provides cloud-based storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file sync and sharing provider. More recently, however, the company has focused on bolstering its product portfolio by adding tools such as governance and e-signature that enhance workflow management and collaboration.
Read more on BOX →About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →
